KU researcher defines shape of enzyme linked to prostate, breast cancers

LAWRENCE – A University of Kansas researcher has made a discovery that should lead to improved treatments for prostate and breast cancer.

Emily Scott, an associate professor of medicinal chemistry at KU, has provided the first experimental evidence regarding the shape of cytochrome P450 17A1 – or CYP17A1 – an enzyme that makes hormones that promote the growth of prostate and breast cancer. By defining the shape of this enzyme, Scott’s research will enable the design of more effective drugs to stop undesirable hormone production in cancer patients.

Read full story.